A page on LabLog, a review site (not the lab's official page)
がん免疫治療臨床免疫学
Showing the original Japanese · View translation
がん免疫療法の効き目と副作用のバランスを最適にする研究室。

AboutAbout the lab
効き目と安全を、両立するがん免疫療法へ。
がん免疫治療臨床免疫学部門は、
抗PD-(L)1療法などのがん免疫療法では、
副作用を
がん免疫総合研究センターの
Key terms
- 免疫関連
有害事象 - がん免疫療法で
免疫が 強まった 結果、 自分の 臓器を 攻撃してしまう 副作用 - 抗PD-(L)1療法
- 免疫の
ブレーキ役の 分子PD-1や PD-L1の 働きを 抗体で 止め、 がんへの 攻撃を 強める 治療 - 複合がん免疫療法
- いく
つかの 治療を 組み合わせる がん免疫療法
ResearchResearch themes
がん免疫療法に
*Illustrative image免疫関連有害事象のしくみと複合がん免疫療法
免疫関連
*Illustrative image病院と連携した有害事象の研究
2021年に
MembersFaculty
- Program-Specific Associate Professor塚本 博丈
- Program-Specific Associate Professor村上 孝作
VoicesStudent voices
Ratings and reviews reflect the experiences of individual current or former students, not the lab's official views. Whether a lab has reviews, or how many, says nothing about the lab itself.
Students who take part in an interview may receive a thank-you gift worth ¥1,000, regardless of what they say.
Student ratings (0 students)
--
--
--
--
--
--
Student voices answer questions like these
- What's great about this lab?
- What did you learn after joining?
- What's the vibe, and what is the professor like?
- Who is this lab for?
- Where do graduates go?
Your experience can help younger students choose their lab. Your name won't be shown.
Write a lab reviewAnonymous · Your draft is saved if you stopRelatedLabs similar to がん免疫治療臨床免疫学
免疫細胞生物学医学部 医学科―ヒト免疫学― 免疫系は
がん免疫治療医学部 医学科私は
分子細胞生理学医学部 医学科意識に
がん免疫応答制御医学部 医学科本部門は、The information on this page is compiled by the LabLog team from the lab's public information and interviews. For corrections or removal requests, please contact LabLog, not the lab.
Report an errorAbout the images
The top and research theme images are illustrative and were not taken at the lab. They are cropped from Wikimedia Commons images. Cropped CC BY-SA images are provided under the same CC BY-SA license as the original (version shown on each line).
- Top image: “PD-1, PD-L1 and CTLA-4 targets of immune checkpoint inhibitors” Alexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, Hélène Blons and Simon Garinet / CC BY 4.0 (cropped)
- 免疫関連
有害事象の しくみと 複合がん免疫療法: “Mechanism of action of PD-1-PD-L1 inhibitors” Feng Li1,Binchi Liao,Ting Wang,Tingting Qi,Yixin Wang / CC BY 4.0 (cropped) - 病院と
連携した 有害事象の 研究: “Kyoto-u” Ayumi2000 / CC BY 3.0 (cropped) - Related lab (免疫細胞生物学): “Follicular helper T (Tfh) and T follicular regulatory (Tfr) cells both act in the germinal center (GC) to regulate the generation of antigen (Ag)-specific antibody-secreting cells” Xie MM and Dent AL / CC BY 4.0 (cropped)
- Related lab (がん免疫治療): “Dendritic Cell (NIH BioArt )” Courtesy of NIAID Ryan Kissinger / Public domain (cropped)
- Related lab (分子細胞生理学): “Taste bud esp” NEUROtiker / CC BY-SA 3.0 (cropped)
- Related lab (がん免疫応答制御): “Mitochondria 2 -- Smart-Servier” Laboratoires Servier / CC BY-SA 3.0 (cropped)
About LabLog
LabLog is a lab review app for students only. Student members at each university interview students in labs and publish what they say. Student voices can only be read by students who sign up with a university email address. Operated by bestiee Inc.
Learn more about LabLog ↗Search engines and AI may reference the basic lab info and rating summaries on this page and the description of LabLog. Student voices are for student members only. Automated collection by programs (scraping, or input to or training of AI) is prohibited under Article 8 of the Terms of Service. If you need data for research or analysis, please contact us.